Femasys (NASDAQ:FEMY) CEO Buys $50,000.00 in Stock

Posted by George Bondi on Aug 14th, 2026

Femasys Inc. (NASDAQ:FEMY – Get Free Report) CEO Kathy Lee-Sepsick purchased 15,625 shares of the firm’s stock in a transaction that occurred on Friday, August 7th. The shares were acquired at an average cost of $3.20 per share, with a total value of $50,000.00. Following the completion of the purchase, the chief executive officer directly owned 15,625 shares in the company, valued at $50,000. The trade was a ∞ increase in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.

Femasys Price Performance

FEMY opened at $2.29 on Friday. The business has a fifty day moving average of $3.67 and a 200 day moving average of $7.35. Femasys Inc. has a 52-week low of $2.19 and a 52-week high of $22.20. The company has a quick ratio of 1.98, a current ratio of 3.91 and a debt-to-equity ratio of 0.53. The stock has a market cap of $6.92 million, a P/E ratio of -0.42 and a beta of -2.08.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on FEMY. Weiss Ratings raised shares of Femasys from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, July 31st. Wall Street Zen raised shares of Femasys to a “hold” rating in a research note on Saturday, June 13th. Two analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Femasys has a consensus rating of “Hold” and an average price target of $80.00.

Get Our Latest Research Report on Femasys

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. Kovack Advisors Inc. purchased a new position in Femasys during the 4th quarter worth $27,000. HRT Financial LP purchased a new stake in shares of Femasys in the 4th quarter worth $30,000. Cetera Investment Advisers bought a new position in shares of Femasys during the 4th quarter worth $36,000. Osaic Holdings Inc. bought a new position in shares of Femasys during the 2nd quarter worth $45,000. Finally, State Street Corp increased its stake in shares of Femasys by 43.5% during the fourth quarter. State Street Corp now owns 80,869 shares of the company’s stock valued at $47,000 after buying an additional 24,500 shares during the period. Institutional investors own 65.27% of the company’s stock.

Femasys Company Profile

(Get Free Report)

Femasys International, Inc is a medical device company focused on the research, development and commercialization of innovative technologies for interventional women’s health applications. The company’s core activities center on creating minimally invasive diagnostic and therapeutic products designed to address uterine cavity evaluation and treatment and to improve outcomes in gynecological care.

The company’s flagship product, the FemVue® hydrosonography system, is a single-use catheter-based device that enhances visualization of the uterine cavity through saline infusion sonography.